Authors:
Ong GS; Somerville CP; Jones TW; Walsh JP
Authors notes:
Case Report Med. 2012;2012:384054
Keywords:
Anaphylactic reaction, Reandron 1000, Complications, Depot Testosterone undecanoate
Abstract
We report the first case of an anaphylactic reaction to Reandron 1000 (depot testosterone undecanoate with a castor oil and benzyl benzoate vehicle).
While considered to have a favourable safety profile, serious complications such as oil embolism and anaphylaxis can occur.
In our patient, skin testing identified benzyl benzoate to be the trigger, with no reaction to castor oil or testosterone undecanoate components.
As benzyl benzoate exists in multiple pharmaceuticals, foods, and cosmetics, individual components of pharmaceuticals should be tested when investigating drug allergies.
Doctors should be alert to the potential for serious reactions to any of the components of Reandron 1000.